Released on 25/11/2018

Key Learning Points

  • Aspirin therapy and Reye syndrome
  • Infliximab
  • Kawasaki disease: acute management
  • Kawasaki disease: cardiovascular complications
  • Kawasaki disease: diagnostic criteria
  • Kawasaki disease: limiting physical activity
  • Kawasaki disease: risk level III
  • Kawasaki disease: the role of cardiac angiography
  • The rapid antigen detection test for group A streptococcus (GAS)


1. HOOKER B. Measles-mumps-rubella vaccination timing and autism among young African American boys: a reanalysis of CDC data. Transl Neurodegener. 2014;3:16 [viewed 26 June 2016]. Available from:
2. ELEFTHERIOU D, LEVIN M, SHINGADAI D, TULLOH R, KLEIN NJ, BROGAN PA. Management of Kawasaki disease. Arch Dis Child. [online] 2014 Jan; 99(1): 74-83 [viewed 26 June 2016]. Available from:
3. BAICUS A. History of polio vaccination World J Virol [online] 2012 Aug 12, 1(4):108-114 [viewed 26 June 2016] Available from:
4. BLUMAN J, GOLDMAN. Henoch-Schönlein purpura in children. Can Fam Physician. [online] 2014 Nov; 60(11): 1007-1010. [viewed 26 June 2016] Available from:
5. BRUCE MG, BRUDEN D, HURLBURT D, ZANIS C, THOMPSON G, REA L, TOOMEY M, TOWNSHEND-BULSON L, RUDOLPH K, BULKOW L, SPRADLING PR, BAUM R, HENNESSY T, MCMAHON BJ. Antibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster Dose. J Infect Dis [online] 2016 Jul 1, 214(1):16-22 [viewed 26 June 2016] Available from:
6. COHEN-PORADOSU R, KASPER DL. Group A streptococcus epidemiology and vaccine implications. Clin Infect Dis [online] 2007 Oct 1, 45(7):863-5 [viewed 26 June 2016] Available from:
7. HENNINGHAM A, BARNETT TC, MAAMARY PG, WALKER MJ. Pathogenesis of Group A Streptococcal Infections. Discov Med. [online] 2012 May;13(72):329-42 [viewed 26 June 2016] Available from:
8. MCCRINDLE B, ROWLEY AH, NEWBURGER JW, BURNS JC, BOLGER AF, GEWITZ M, AL BAKER, JACKSON MA, TAKAHASHI M, SHAH PB, KOBAYASHI T, WU M, SAJI TT, PAHL E. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation. [online] 2017; 137 (10): CIR.0000000000000484. [viewed 8 March 2018] Available from:
9. NEWBURGER JW, TAKAHASHI M, GERBER MA, GEWITZ MH, TANI LY, BURNS JC, SHULMAN ST, BOLGER AF, FERRIERI P, BALTIMORE RS, WILSON WR, BADDOUR LM, LEVISON ME, PALLASCH TJ, FALACE DA, TAUBERT KA, COMMITTEE ON RHEUMATIC FEVER, ENDOCARDITIS AND KAWASAKI DISEASE, COUNCIL ON CARDIOVASCULAR DISEASE IN THE YOUNG, AMERICAN HEART ASSOCIATION, AMERICAN ACADEMY OF PEDIATRICS. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation [online] 2004 Oct 26, 110(17):2747-71 [viewed 26 June 2016] Available from:
10. JCS JOINT WORKING GROUP. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013). Digest version. Circ J [online] 2014, 78(10):2521-62 [viewed 26 June 2016] Available from:
11. SAGUIL A, FARGO M, GROGAN S. Diagnosis and management of kawasaki disease. Am Fam Physician [online] 2015 Mar 15, 91(6):365-71 [viewed 26 June 2016] Available from: